Transo-Pharm focus on API’s for the generic market; a distinctive offer has been built by this privately owned company over many years. Their unique capability to offer regulatory support, combined with the shared service provided by our Chemical and Regulatory experts, means that our clients are supported within the framework of ever increasing regulation.

Learn More

Ask A Technical Question

About this product

Digoxin slows the heart rate but increases stroke volume, providing an increase in blood pressure which help relieve atrial fibrillation, atrial flutter, and heart failure

Make an Enquiry